IL103396A - Cyclic derivatives of the vasoactive intestinal peptide, their preparation and pharmaceutical compositions containing them - Google Patents

Cyclic derivatives of the vasoactive intestinal peptide, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103396A
IL103396A IL103396A IL10339692A IL103396A IL 103396 A IL103396 A IL 103396A IL 103396 A IL103396 A IL 103396A IL 10339692 A IL10339692 A IL 10339692A IL 103396 A IL103396 A IL 103396A
Authority
IL
Israel
Prior art keywords
peptide
pharmaceutical compositions
preparation
amino acid
compositions containing
Prior art date
Application number
IL103396A
Other languages
English (en)
Other versions
IL103396A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to IL11725292A priority Critical patent/IL117252A/xx
Publication of IL103396A0 publication Critical patent/IL103396A0/xx
Publication of IL103396A publication Critical patent/IL103396A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57563Vasoactive intestinal peptide [VIP]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/17Vasoactive intestinal peptides; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL103396A 1991-10-11 1992-10-09 Cyclic derivatives of the vasoactive intestinal peptide, their preparation and pharmaceutical compositions containing them IL103396A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11725292A IL117252A (en) 1991-10-11 1992-10-09 Cyclic derivatives of the vasoactive intestinal peptide their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77374791A 1991-10-11 1991-10-11

Publications (2)

Publication Number Publication Date
IL103396A0 IL103396A0 (en) 1993-03-15
IL103396A true IL103396A (en) 1997-11-20

Family

ID=25099195

Family Applications (3)

Application Number Title Priority Date Filing Date
IL103396A IL103396A (en) 1991-10-11 1992-10-09 Cyclic derivatives of the vasoactive intestinal peptide, their preparation and pharmaceutical compositions containing them
IL11725292A IL117252A (en) 1991-10-11 1992-10-09 Cyclic derivatives of the vasoactive intestinal peptide their preparation and pharmaceutical compositions containing them
IL11725296A IL117252A0 (en) 1991-10-11 1996-02-23 Cyclic derivatives of the vasoactive intestinal peptide their preparation and pharmaceutical compositions containing them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL11725292A IL117252A (en) 1991-10-11 1992-10-09 Cyclic derivatives of the vasoactive intestinal peptide their preparation and pharmaceutical compositions containing them
IL11725296A IL117252A0 (en) 1991-10-11 1996-02-23 Cyclic derivatives of the vasoactive intestinal peptide their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (1) US5677419A (fr)
EP (1) EP0536741B1 (fr)
JP (1) JP2515473B2 (fr)
KR (1) KR970001580B1 (fr)
CN (3) CN1034943C (fr)
AT (1) ATE132165T1 (fr)
AU (1) AU656230B2 (fr)
BG (1) BG61125B2 (fr)
BR (1) BR9203959A (fr)
CA (1) CA2080272C (fr)
CZ (1) CZ281818B6 (fr)
DE (1) DE69207138T2 (fr)
DK (1) DK0536741T3 (fr)
ES (1) ES2082317T3 (fr)
FI (2) FI111646B (fr)
GR (1) GR3019326T3 (fr)
HU (2) HUT62606A (fr)
IL (3) IL103396A (fr)
MX (1) MX9205822A (fr)
NO (3) NO304523B1 (fr)
NZ (1) NZ244644A (fr)
RU (1) RU2095368C1 (fr)
SK (1) SK279399B6 (fr)
TW (1) TW305846B (fr)
UY (2) UY23488A1 (fr)
ZA (1) ZA927724B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
KR100493795B1 (ko) * 1996-02-09 2005-09-09 에프. 호프만-라 로슈 아게 혈관활성장펩타이드유사체의합성방법
JP3647881B2 (ja) * 1996-07-12 2005-05-18 イムノメディクス,インコーポレイテッド 放射性金属元素結合ペプチドの類似化合物
WO1998002453A2 (fr) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Ligands peptidiques possedant une selectivite plus elevee pour le recepteur vip1 que pour le recepteur vip¿2?
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
DE60039111D1 (de) * 1999-09-28 2008-07-17 Bayer Corp Agonisten des rezeptors 3 (r3) von pituitary adenylate cyclase aktivierendem peptid (pacap) und ihre pharmakologische verwendung
US6489297B1 (en) 2000-02-18 2002-12-03 Dabur Research Foundation Vasoactive intestinal peptide analogs
EP1257575B1 (fr) 2000-02-18 2007-02-28 Dabur Research Foundation Analogues radiomarques de peptide intestinal vasoactif destines au diagnostic et a la radiotherapie
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
US7507714B2 (en) * 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
US20040063631A1 (en) 2000-11-28 2004-04-01 Lutz-Henning Block Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
HK1080363B (zh) 2002-06-10 2007-12-21 Mondobiotech Ag 具有血管活性肠肽的生物学活性的化合物在治疗结节病中的用途
JP2007519739A (ja) * 2004-01-27 2007-07-19 バイエル・フアーマシユーチカルズ・コーポレーシヨン 下垂体細胞アデニル酸シクラーゼ活性化ペプチド(pacap)受容体(vcap2)アゴニストおよびそれらの製薬学的使用方法
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
CA2577326A1 (fr) * 2004-08-18 2006-03-02 Eli Lilly & Company Recepteur selectif vpac2 pour agonistes peptidiques
RU2304146C2 (ru) * 2005-10-17 2007-08-10 Закрытое акционерное общество "Эпитек" Способ стабилизации петлеобразной структуры синтетических пептидов с помощью n- и c-концевых модификаций
CA2638733A1 (fr) * 2006-02-28 2007-09-07 Eli Lilly And Company Agonistes peptidiques selectifs du recepteur vpac2
BRPI0714306A2 (pt) * 2006-07-06 2014-05-20 Hoffmann La Roche Análogos do peptídio intestinal vasoativo
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
PL3311828T3 (pl) 2009-08-14 2021-11-22 Phasebio Pharmaceuticals, Inc. Zmodyfikowane wazoaktywne peptydy jelitowe
CA2797033C (fr) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Polypeptides tres actifs et procedes pour les preparer et les utiliser
CA2873553C (fr) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Utilisation de peptides intestinaux vasoactifs (piv) modifies pour traiter l'hypertension
WO2014145718A2 (fr) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
CA2976038A1 (fr) 2015-02-09 2016-08-18 Phasebio Pharmaceuticals, Inc. Methodes et compositions pour traiter des maladies et des troubles musculaires
BR112019006301A2 (pt) 2016-09-30 2019-07-30 Fujifilm Corp peptídeo cíclico, suporte de cromatografia de afinidade, anticorpo marcado, conjugado anticorpo - fármaco, e preparação farmacêutica
AU2021224412A1 (en) * 2020-02-22 2022-09-15 Jcr Pharmaceuticals Co., Ltd. Human transferrin receptor binding peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
CN1198841C (zh) 2005-04-27
NO304523B1 (no) 1999-01-04
CZ281818B6 (cs) 1997-02-12
DE69207138T2 (de) 1996-06-13
CN1225473C (zh) 2005-11-02
CA2080272A1 (fr) 1993-04-12
CN1152579A (zh) 1997-06-25
JP2515473B2 (ja) 1996-07-10
IL103396A0 (en) 1993-03-15
TW305846B (fr) 1997-05-21
NO980377L (no) 1993-04-13
EP0536741A2 (fr) 1993-04-14
ZA927724B (en) 1994-04-07
FI924580L (fi) 1993-04-12
SK279399B6 (sk) 1998-11-04
CZ308692A3 (en) 1993-08-11
HUT62606A (en) 1993-05-28
DE69207138D1 (de) 1996-02-08
US5677419A (en) 1997-10-14
KR970001580B1 (ko) 1997-02-11
CN1153785A (zh) 1997-07-09
CA2080272C (fr) 2002-09-17
CN1072415A (zh) 1993-05-26
FI924580A0 (fi) 1992-10-09
NO923929L (no) 1993-04-13
IL117252A0 (en) 1996-06-18
RU2095368C1 (ru) 1997-11-10
BG61125B2 (bg) 1996-11-29
HU211534A9 (en) 1995-12-28
GR3019326T3 (en) 1996-06-30
FI111646B (fi) 2003-08-29
FI20002041A7 (fi) 2000-09-15
HU9203194D0 (en) 1992-12-28
AU656230B2 (en) 1995-01-27
NZ244644A (en) 1995-04-27
JPH05213996A (ja) 1993-08-24
IL117252A (en) 1999-11-30
NO975023L (no) 1993-04-13
BR9203959A (pt) 1993-04-27
DK0536741T3 (da) 1996-04-22
UY25084A1 (es) 1998-12-21
NO923929D0 (no) 1992-10-09
NO980377D0 (no) 1998-01-28
MX9205822A (es) 1993-06-01
AU2622892A (en) 1993-04-22
SK308692A3 (en) 1995-03-08
EP0536741B1 (fr) 1995-12-27
ATE132165T1 (de) 1996-01-15
UY23488A1 (es) 1993-04-20
FI20002041L (fi) 2000-09-15
KR930007972A (ko) 1993-05-20
NO975023D0 (no) 1997-10-31
CN1034943C (zh) 1997-05-21
ES2082317T3 (es) 1996-03-16
EP0536741A3 (fr) 1994-04-06

Similar Documents

Publication Publication Date Title
IL103396A (en) Cyclic derivatives of the vasoactive intestinal peptide, their preparation and pharmaceutical compositions containing them
EP0662827A4 (fr) Procedes therapeutiques et diagnostiques et compositions a base de proteines notch et d'acides nucleiques.
EP1990409A3 (fr) Bactériophage
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
CA2229544A1 (fr) Analogues peptides cycliques de somatostatine
EP0180921A3 (fr) Procédé de préparation et de purification de peptides
IE902388L (en) Vasoactive intestinal peptide analogs.
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
AU2043388A (en) Cyclic peptides as promoters of absorption on administration onto the mucosa
HU896448D0 (en) Process for the preparation of anticoagulant peptides
AU585167B2 (en) Novel substrate peptides
IL99924A0 (en) Derivatives of structurally modified vip and pharmaceutical compositions containing them
DE3361591D1 (en) Polypeptides with an antagonistic activity on substance p, process for their preparation, their use and process for the purification of polypeptides
GR3006982T3 (fr)
EP0342015A3 (fr) Peptides, leur emploi et les compositions pharmaceutiques les contenant
MX9707904A (es) Analogos del factor de liberacion de la hormona del crecimiento.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force